Efficacy and Safety of Two Neoadjuvant Strategies With Bevacizumab in MRI-Defined Locally Advanced T3 Resectable Rectal Cancer: Final Results of a Randomized, Noncomparative Phase 2 INOVA Study
Author:
Funder
Roche
Amgen
Merck
Sanofi
Bayer
SAS
Publisher
Elsevier BV
Subject
Gastroenterology,Oncology
Reference40 articles.
1. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Glynne-Jones;Ann Oncol,2017
2. Does delaying adjuvant chemotherapy after curative surgery for colorectal cancer impair survival? A meta-analysis;Des Guetz;Eur J Cancer,2010
3. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years;Sauer;J Clin Oncol,2012
4. Clinical outcome of the ACCORD 12/0405 PRODIGE 2 randomized trial in rectal cancer;Gerard;J Clin Oncol,2012
5. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial;Rodel;Lancet Oncol,2015
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Total neoadjuvant therapy in rectal cancer: the evidence and expectations;Critical Reviews in Oncology/Hematology;2023-12
2. Radiotherapy in the preoperative neoadjuvant treatment of locally advanced rectal cancer;Frontiers in Oncology;2023-11-23
3. Total neoadjuvant treatment and organ preservation strategies in the management of localized rectal cancer: A narrative review and evidence-based algorithm;Critical Reviews in Oncology/Hematology;2023-06
4. Adding Induction Chemotherapy Before Chemoradiotherapy with Total Mesorectal Excision and Selective Lateral Lymph Node Dissection for Patients with Poor-Risk, Locally Advanced, Mid-to-Low Rectal Cancer May Improve Oncologic Outcomes: A Propensity Score-Matched Analysis;Annals of Surgical Oncology;2023-04-09
5. A systematic review and network meta-analysis of randomised controlled trials comparing neoadjuvant treatment strategies for stage II and III rectal cancer;Critical Reviews in Oncology/Hematology;2023-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3